Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer. Freedland SJ, de Almeida Luz M, De Giorgi U, Gleave M, et al. N Engl J Med 2023;389:1453-1465.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Freedland SJ, de Almeida Luz M, De Giorgi U, Gleave M, et al. Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer. N Engl J Med 2023;389:1453-1465.
PMID: 37851874